Come up with a name for your new list and we'll add to it:
Arcturus Therapeutics raised a round of funding on May 31, 2017. Investors include
Cystic Fibrosis Foundation.
Arcturus Therapeutics, a San Diego-based company focused on the discovery and development of therapeutic modalities, was founded in 2013 to pursue RNA interference (RNAi) solutions for rare diseases f…